Market Cap 318.84M
Revenue (ttm) 57.56M
Net Income (ttm) -44.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -76.69%
Debt to Equity Ratio -0.55
Volume 1,209,800
Avg Vol 1,549,116
Day's Range N/A - N/A
Shares Out 99.33M
Stochastic %K 25%
Beta 1.94
Analysts Strong Sell
Price Target $8.42

Company Profile

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 908 941 1900
Address:
30 Technology Drive, Warren, United States
GoldenReign
GoldenReign Jun. 25 at 10:03 PM
$AQST you seem worried about your shot in the dark aqst. Quit trying to compare the two and do your own due diligence instead of coming to the SPRY board to spread FUD. You aqst trolls are giving troll fatigue 😩
1 · Reply
h8ster
h8ster Jun. 25 at 10:00 PM
$AQST So, I've went over multiple CC transcripts again. A few times, rereading everything twice, thrice, etc. My anticipation of a US /global partnership are being toned down. The odds of them launching it in the US, given the amount of time/money/hiring they have already committed to are quite high. And thats not a bad thing. Their actual commitment to ex-US partnerships is quite high and have been consistent Q over Q. That kind of partnership, if completed before approval could supply the company with the cash it needs, rather than be forced to do an offering or an ATM tap To quote Barber from the last CC, see attachments, they should have an ex-US partnership in hand prior to FDA approval.
4 · Reply
prototyper
prototyper Jun. 25 at 9:02 PM
$AQST @h8ster Are tutes gonna tell us when they wanna see this higher going into FDA approval date? At some point, this thing has to move up right? with volume obviously nearing the date or maybe way before? Like the big push we just had, i think we could probably tell from big huge volume it will bring when tutes wanna see this go up. I guess our hands are all tied then. Good luck to all of us. 🙈
1 · Reply
Biotechnicity
Biotechnicity Jun. 25 at 8:42 PM
Holding my $AQST position and adding in the mid to upper two’s if we ever get the opportunity. BO’s and Partner’s are rare and hard to find. I do believe in the products and am willing to play the game. To sell only in shades of green far darker than my shades are today.
1 · Reply
h8ster
h8ster Jun. 25 at 8:14 PM
$AQST Anybody here playing the annual Russell Reconstitution that takes effect on Friday? Ton of funds will be exiting plays and going into new ones. All algo initiated. It was one of the catalysts that helped kickstart AQST's uptrend last year when they got added. They are remaining on it for this year as they continue to exceed all the requirements. One of the reasons we are seeing volatility in the Russell right now. Ton of moves being made this week. You'll all see massive volume spikes eod Friday in all plays that are involved. Not so much pps surges, although some might. It's a fun game to play. I don't have any picks right now. Mayne I'll come up with some later. Right now, I'm busy having a load of fun with AQST, taking shares from the weak. Anyway, if anybody is playing it, send me a ticker.
1 · Reply
AnalyticalDog
AnalyticalDog Jun. 25 at 7:48 PM
$AQST besides neffy, why on earth is $SPRY at 1.7 billion market cap? Even optimistic market projections for anaphylm don’t put aqst at 1.7 billion by 2030
4 · Reply
Outrageous
Outrageous Jun. 25 at 6:36 PM
$AQST Aquestive Therapeutics: Updating The Anaphylm Timeline To Approval Jun. 25, 2025 8:03 AM ETAquestive Therapeutics, https://seekingalpha.com/article/4797134-aquestive-therapeutics-updating-the-anaphylm-timeline-to-approval
OracleofOntario
OracleofOntario Jun. 25 at 6:28 PM
$AQST best bet out there - just need to hold until early next year, then kaboom!
1 · Reply
h8ster
h8ster Jun. 25 at 5:33 PM
$AQST Here are the posters they will be presenting this weekend at CFAAR. Each time they present these things, it's like a mini AdCom. A lot of big companies will there for the presentations. Huge opportunity for AQST to get the word out. June 28: The Physicochemical Properties of Anaphylm Under Extreme Temperatures and Real-World Conditions. https://aquestive.com/content/uploads/Poster-304.-Durability-of-Epinephrine-Sublingual-Film-Under-Real-World-Use_FINAL.pdf https://aquestive.com/content/uploads/Poster-305.-Stability-Results-of-Epinephrine-Sublingual-Film-Under-Extreme-Temperature-Conditions%E2%80%8B_FINAL.pdf June 28: Epinephrine Delivered via Sublingual Film (Anaphylm) Elicits Rapid and Consistent Pharmacokinetic and Pharmacodynamic Responses https://aquestive.com/content/uploads/Poster-312.-Epinephrine-Delivered-via-Sublingual-Film-AnaphylmTM-Elicits-Rapid-and-Consistent-Pharmacokinetic-and-Pharmacodynamic-Responses%E2%80%8B_F.pdf
0 · Reply
shawn45
shawn45 Jun. 25 at 5:16 PM
$OTLK $AQST $AMZN $NVDA $AMD OTLK Will receive US FDA Approval in August 27th for the BLA Drug. Potential for early approval in August 1st week aswell (90% chance). Manufacturing issues resolved and FDA requested 2nd studies were completed successfully and FDA also reviewed it already. Thats the reason why they have provided PDUFA for final review and for approval. High chance OTLK stock will hit 10+ upon US FDA APPROVAL. Possible this stock will move to 7+ bucks trade before approval aswell. All 5 great stocks OTLK, NVDA, AQST, AMZN, AMD to hold for long term
2 · Reply
Latest News on AQST
Aquestive Therapeutics: Five Foci For 2025

Jan 6, 2025, 12:13 AM EST - 6 months ago

Aquestive Therapeutics: Five Foci For 2025


Aquestive: Rare Opportunity With Dual Platform Strategy

Nov 5, 2024, 2:09 PM EST - 8 months ago

Aquestive: Rare Opportunity With Dual Platform Strategy


Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings

Aug 22, 2024, 11:37 PM EDT - 10 months ago

Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings


Aquestive Therapeutics Provides Business Update

Oct 9, 2023, 8:00 AM EDT - 1 year ago

Aquestive Therapeutics Provides Business Update


GoldenReign
GoldenReign Jun. 25 at 10:03 PM
$AQST you seem worried about your shot in the dark aqst. Quit trying to compare the two and do your own due diligence instead of coming to the SPRY board to spread FUD. You aqst trolls are giving troll fatigue 😩
1 · Reply
h8ster
h8ster Jun. 25 at 10:00 PM
$AQST So, I've went over multiple CC transcripts again. A few times, rereading everything twice, thrice, etc. My anticipation of a US /global partnership are being toned down. The odds of them launching it in the US, given the amount of time/money/hiring they have already committed to are quite high. And thats not a bad thing. Their actual commitment to ex-US partnerships is quite high and have been consistent Q over Q. That kind of partnership, if completed before approval could supply the company with the cash it needs, rather than be forced to do an offering or an ATM tap To quote Barber from the last CC, see attachments, they should have an ex-US partnership in hand prior to FDA approval.
4 · Reply
prototyper
prototyper Jun. 25 at 9:02 PM
$AQST @h8ster Are tutes gonna tell us when they wanna see this higher going into FDA approval date? At some point, this thing has to move up right? with volume obviously nearing the date or maybe way before? Like the big push we just had, i think we could probably tell from big huge volume it will bring when tutes wanna see this go up. I guess our hands are all tied then. Good luck to all of us. 🙈
1 · Reply
Biotechnicity
Biotechnicity Jun. 25 at 8:42 PM
Holding my $AQST position and adding in the mid to upper two’s if we ever get the opportunity. BO’s and Partner’s are rare and hard to find. I do believe in the products and am willing to play the game. To sell only in shades of green far darker than my shades are today.
1 · Reply
h8ster
h8ster Jun. 25 at 8:14 PM
$AQST Anybody here playing the annual Russell Reconstitution that takes effect on Friday? Ton of funds will be exiting plays and going into new ones. All algo initiated. It was one of the catalysts that helped kickstart AQST's uptrend last year when they got added. They are remaining on it for this year as they continue to exceed all the requirements. One of the reasons we are seeing volatility in the Russell right now. Ton of moves being made this week. You'll all see massive volume spikes eod Friday in all plays that are involved. Not so much pps surges, although some might. It's a fun game to play. I don't have any picks right now. Mayne I'll come up with some later. Right now, I'm busy having a load of fun with AQST, taking shares from the weak. Anyway, if anybody is playing it, send me a ticker.
1 · Reply
AnalyticalDog
AnalyticalDog Jun. 25 at 7:48 PM
$AQST besides neffy, why on earth is $SPRY at 1.7 billion market cap? Even optimistic market projections for anaphylm don’t put aqst at 1.7 billion by 2030
4 · Reply
Outrageous
Outrageous Jun. 25 at 6:36 PM
$AQST Aquestive Therapeutics: Updating The Anaphylm Timeline To Approval Jun. 25, 2025 8:03 AM ETAquestive Therapeutics, https://seekingalpha.com/article/4797134-aquestive-therapeutics-updating-the-anaphylm-timeline-to-approval
OracleofOntario
OracleofOntario Jun. 25 at 6:28 PM
$AQST best bet out there - just need to hold until early next year, then kaboom!
1 · Reply
h8ster
h8ster Jun. 25 at 5:33 PM
$AQST Here are the posters they will be presenting this weekend at CFAAR. Each time they present these things, it's like a mini AdCom. A lot of big companies will there for the presentations. Huge opportunity for AQST to get the word out. June 28: The Physicochemical Properties of Anaphylm Under Extreme Temperatures and Real-World Conditions. https://aquestive.com/content/uploads/Poster-304.-Durability-of-Epinephrine-Sublingual-Film-Under-Real-World-Use_FINAL.pdf https://aquestive.com/content/uploads/Poster-305.-Stability-Results-of-Epinephrine-Sublingual-Film-Under-Extreme-Temperature-Conditions%E2%80%8B_FINAL.pdf June 28: Epinephrine Delivered via Sublingual Film (Anaphylm) Elicits Rapid and Consistent Pharmacokinetic and Pharmacodynamic Responses https://aquestive.com/content/uploads/Poster-312.-Epinephrine-Delivered-via-Sublingual-Film-AnaphylmTM-Elicits-Rapid-and-Consistent-Pharmacokinetic-and-Pharmacodynamic-Responses%E2%80%8B_F.pdf
0 · Reply
shawn45
shawn45 Jun. 25 at 5:16 PM
$OTLK $AQST $AMZN $NVDA $AMD OTLK Will receive US FDA Approval in August 27th for the BLA Drug. Potential for early approval in August 1st week aswell (90% chance). Manufacturing issues resolved and FDA requested 2nd studies were completed successfully and FDA also reviewed it already. Thats the reason why they have provided PDUFA for final review and for approval. High chance OTLK stock will hit 10+ upon US FDA APPROVAL. Possible this stock will move to 7+ bucks trade before approval aswell. All 5 great stocks OTLK, NVDA, AQST, AMZN, AMD to hold for long term
2 · Reply
h8ster
h8ster Jun. 25 at 4:49 PM
$AQST AQST & SPRY are silver sponsors at CFAAR this week. Lol. You think it will be awkward in the room? Lol. What a turn of events it would be if SPRY somehow managed to buyout AQST. Somebody is going to, why not them? Stranger things happen every day.
2 · Reply
InnerVoice
InnerVoice Jun. 25 at 3:41 PM
$AQST I see 6's. Load up.
0 · Reply
WaspofWallStreet
WaspofWallStreet Jun. 25 at 3:15 PM
$AQST added @ 3.13.
1 · Reply
TIG2
TIG2 Jun. 25 at 3:03 PM
$AQST It's Alive...Hope the Duck-Tape holds...Anyhow Pub time...Happy Hump-Day...
0 · Reply
h8ster
h8ster Jun. 25 at 2:45 PM
$AQST the Russell index is going to be volatile heading into the end of the week, with the reconstitution set to take affect on Friday. Lotta companies being kicked off, lotta companies being added. Healthcare sector should be volatile as a result as well, especially the smaller, clinical stage ones
0 · Reply
GreenTwinkie
GreenTwinkie Jun. 25 at 2:23 PM
0 · Reply
Arroin
Arroin Jun. 25 at 2:23 PM
$AQST Keep buying this one as it goes down. It is inevitable it will go to $4 By EOY.
1 · Reply
TIG2
TIG2 Jun. 25 at 2:19 PM
$AQST Come on 10:30 show us something...
0 · Reply
Skinny__
Skinny__ Jun. 25 at 2:10 PM
$AQST it amazes me how many people come here to complain non stop, yet won’t sell and move on. This board is totally insufferable sometimes.
2 · Reply
TIG2
TIG2 Jun. 25 at 1:58 PM
$AQST It's like watching Secretariat against a donkey...
0 · Reply
111ggg
111ggg Jun. 25 at 1:38 PM
$AQST Management wasting more money with these conferences. They simply reiterate data that has already been released. I guess they have nothing else to do until next year. How about laying off some staff. What are they all doing?
0 · Reply
Stone52
Stone52 Jun. 25 at 1:35 PM
$AQST Bull flag has reverted into a downtrend unless today ends up with a big green candle.
1 · Reply